YDR109C Antibody

What is YDR109C and why is it significant for research?

YDR109C is a gene in Saccharomyces cerevisiae (budding yeast) that encodes a protein belonging to the FGGY kinase superfamily. Despite being previously annotated as an uncharacterized open reading frame in the Saccharomyces Genome Database (SGD), research has demonstrated that YDR109C is actively transcribed in S. cerevisiae and produces a detectable protein product (approximately 119 molecules per cell) . The protein's significance lies in its function as a kinase that preferentially phosphorylates D-ribulose as a substrate . YDR109C contains conserved FGGY_N and FGGY_C domains, which are characteristic of the FGGY protein superfamily of sugar kinases . Understanding YDR109C function contributes to our knowledge of fundamental cellular metabolism, particularly sugar-phosphate pathways in eukaryotes.

How is YDR109C gene expression verified in experimental settings?

YDR109C gene expression can be reliably verified using quantitative RT-PCR. In experimental conditions, YDR109C transcript is readily detectable in exponentially growing wild-type cells with an average cycle threshold (Ct) value of 26.3 ± 0.3 (mean ± S.D.; n = 3), compared to the commonly used reference gene ALG9 (mannosyltransferase) which displays a Ct value of 23.8 ± 0.5 (mean ± S.D.; n = 3) . Researchers should design primers specific to the YDR109C sequence and include appropriate controls, including a YDR109C knockout strain where the transcript should be undetectable, as demonstrated in previous studies . Additionally, transcript levels can be compared across different growth conditions to assess regulation patterns.

What is the molecular weight of the YDR109C protein and how can it be detected?

The YDR109C protein has an expected molecular weight of approximately 83 kDa, which can be detected via SDS-PAGE analysis. For definitive identification, Western blotting techniques using specific antibodies are recommended. Previous research has successfully employed epitope tagging strategies, such as adding a His-tag to the protein, which allows detection using commercial anti-His antibodies . This approach produces a distinct band at the expected size (83 kDa) in Western blot analyses, confirming protein expression. Alternative detection methods include mass spectrometry-based proteomics, which has previously quantified YDR109C at approximately 119 molecules per cell .

What metabolite changes are associated with YDR109C deletion?

Deletion of YDR109C results in significant metabolic alterations, most notably the substantial accumulation of ribulose. Metabolomic analysis using ZIC-HILIC-ddMS2 methods revealed ribulose as the metabolite with the highest fold change (>30-fold increase) in YDR109C knockout strains compared to wild type . This finding was consistent across different genetic backgrounds. Additionally, ribitol levels were significantly altered in both genetic backgrounds tested.

Broader metabolite profiling revealed the following patterns:

How does multivariate statistical analysis help characterize YDR109C function?

Multivariate statistical approaches, particularly Principal Component Analysis (PCA) and Partial Least Squares-Discriminant Analysis (PLS-DA), provide powerful tools for characterizing the metabolic consequences of YDR109C deletion. PCA of mTIC-normalized negative and positive mode data from prototrophic strains demonstrated clear separation between wild-type and YDR109C knockout samples, with all replicates falling within the 95% confidence interval of their respective group centroids .

PLS-DA, a supervised method, further confirmed this separation and identified features important for differentiating between wild-type and knockout strains. This approach revealed that while many metabolites showed altered levels, ribulose consistently emerged as the most significantly affected metabolite . Importantly, when applying the same analytical methods to data from auxotrophic strains, the metabolic profiles were much more similar between wild-type and knockout strains, with fewer significantly changed metabolites .

This contrast between genetic backgrounds emphasizes the importance of comparing results across different strains to identify core functions (ribulose metabolism) versus strain-specific effects. Researchers studying YDR109C should consider employing these multivariate approaches to comprehensively characterize the metabolic impact of YDR109C manipulation in their specific experimental systems.

What techniques can be used to verify YDR109C antibody specificity?

Verifying antibody specificity for YDR109C requires multiple complementary approaches:

• Western blot analysis with positive and negative controls: Protein extracts from wild-type yeast expressing YDR109C should show a specific band at 83 kDa, while extracts from YDR109C knockout strains should show no band at this position . This comparison provides the most direct validation of antibody specificity.

• Epitope-tagged protein expression: Expression of YDR109C with an epitope tag (such as His-tag) allows parallel detection with both the YDR109C antibody and a commercial antibody against the tag . Colocalization of signals confirms antibody specificity.

• Immunoprecipitation followed by mass spectrometry: Immunoprecipitation using the YDR109C antibody followed by mass spectrometry analysis of the precipitated proteins can confirm that YDR109C is the primary target being pulled down.

• Peptide competition assay: Pre-incubation of the antibody with the peptide used for immunization should block binding in subsequent applications if the antibody is specific.

• Cross-species validation: Testing the antibody against homologs from related species with varying degrees of sequence conservation can provide information about epitope specificity.

How can researchers distinguish the functional impact of YDR109C from indirect metabolic effects?

Distinguishing direct from indirect metabolic effects of YDR109C requires multiple experimental approaches:

• Complementation studies: Re-introducing YDR109C into knockout strains should rescue the primary phenotypes directly related to YDR109C function, particularly ribulose accumulation .

• Comparative analysis across genetic backgrounds: As demonstrated in the literature, comparing metabolic changes across different strain backgrounds (e.g., prototrophic and auxotrophic) helps identify core metabolic changes (like ribulose accumulation) versus background-specific effects .

• In vitro enzymatic assays: Purified YDR109C protein can be used in controlled enzymatic assays to directly assess its activity on potential substrates, confirming which reactions it catalyzes .

• Metabolic flux analysis: Using isotope-labeled substrates can help trace metabolic pathways and identify where YDR109C directly impacts metabolic flux versus downstream compensatory changes.

• Time-course experiments: Monitoring metabolic changes immediately after conditional inactivation of YDR109C versus long-term adaptation can separate primary from secondary effects.

• Substrate specificity profiling: Testing multiple potential substrates in parallel provides evidence for the preferred biological role of YDR109C as a ribulokinase rather than involvement in other pathways .

What are the optimal protocols for detecting YDR109C using immunoblotting techniques?

For optimal immunoblotting detection of YDR109C, the following protocol is recommended based on successful previous applications:

• Sample preparation: Extract total proteins from yeast cells using mechanical disruption (glass beads) in a buffer containing protease inhibitors. For maximum protein recovery, use a buffer containing 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, and a protease inhibitor cocktail.

• Protein quantification: Use the Bradford or BCA assay to normalize protein loading (25-50 μg of total protein per lane is typically sufficient).

• SDS-PAGE separation: Use 8-10% polyacrylamide gels to provide optimal resolution around the 83 kDa size of YDR109C .

• Transfer conditions: Transfer proteins to PVDF or nitrocellulose membranes using semi-dry or wet transfer systems (25V for 30 minutes in semi-dry systems or 100V for 1 hour in wet systems).

• Blocking: Block membranes with 5% non-fat dry milk in TBST (TBS with 0.1% Tween-20) for 1 hour at room temperature.

• Primary antibody incubation: Dilute YDR109C antibody (typical working dilutions range from 1:1000 to 1:5000) in blocking buffer and incubate overnight at 4°C with gentle agitation.

• Washing: Wash membranes 3 times for 10 minutes each with TBST.

• Secondary antibody incubation: Incubate with appropriate HRP-conjugated secondary antibody (typically 1:5000 to 1:10000) for 1 hour at room temperature.

• Detection: Use enhanced chemiluminescence (ECL) substrate and image using a digital imaging system or X-ray film.

• Controls: Always include a YDR109C knockout strain as a negative control and, if available, a strain overexpressing YDR109C as a positive control .

What mass spectrometry approaches are most effective for studying YDR109C function?

Mass spectrometry (MS) offers powerful approaches for studying YDR109C function, particularly in identifying its substrates and products. Based on successful research strategies, the following MS approaches are recommended:

• Untargeted metabolomics using LC-HRMS: This approach allows comprehensive profiling of metabolic changes in YDR109C knockout versus wild-type strains. ZIC-HILIC (Zwitterionic Hydrophilic Interaction Liquid Chromatography) coupled to high-resolution mass spectrometry has successfully identified ribulose accumulation in YDR109C knockout strains .

• Dual-mode ionization: Analyzing samples in both negative and positive ionization modes increases metabolite coverage. Previous studies found significant metabolite changes in both modes (92 in negative mode and 213 in positive mode in prototrophic strains) .

• Data-dependent MS2 (ddMS2): This method increases metabolite identification potential by generating fragmentation patterns (MS2 spectra) that can be matched against standards .

• Targeted MS methods: Once candidate metabolites are identified (like ribulose), targeted methods can provide more sensitive and specific quantification.

• Multiple chromatography methods: Complementary approaches such as ZIC-HILIC and reverse phase chromatography maximize metabolite coverage .

• Co-cultivation method: This technique helps confirm that detected metabolites are produced endogenously rather than derived from media components .

• Statistical analysis: Apply multivariate statistical approaches (PCA and PLS-DA) to identify significantly changed metabolites and patterns across conditions .

How can researchers create and validate YDR109C knockout models?

Creating and validating YDR109C knockout models requires careful attention to both genetic manipulation and phenotypic confirmation:

• Knockout generation methods:

  • Homologous recombination using PCR-amplified deletion cassettes (most common)

  • CRISPR-Cas9 gene editing for precise modifications

  • Transposon-based disruption methods

• Validation of knockout at the DNA level:

  • PCR verification using primers flanking the expected deletion site

  • Sequencing of the modified locus to confirm complete gene removal

• Validation of knockout at the RNA level:

  • RT-PCR or quantitative RT-PCR to confirm absence of YDR109C transcript

  • Previous research demonstrated undetectable YDR109C transcript in knockout strains compared to clear detection in wild-type (Ct value of 26.3 ± 0.3)

• Validation of knockout at the protein level:

  • Western blotting using YDR109C antibodies to confirm absence of the protein

  • Mass spectrometry-based proteomics to confirm protein absence

• Phenotypic validation:

  • Metabolomics analysis showing expected accumulation of ribulose (>30-fold increase)

  • Functional complementation: reintroducing YDR109C should rescue the metabolic phenotype

• Controls and background considerations:

  • Include isogenic wild-type controls

  • Consider creating knockouts in multiple genetic backgrounds, as some phenotypes may be background-specific

  • Use marker-free deletion strategies when possible to avoid marker effects

What enzymatic assay systems can accurately measure YDR109C kinase activity?

To accurately measure YDR109C kinase activity, researchers should consider the following enzymatic assay systems:

• Purified protein preparation:

  • Express recombinant YDR109C with an affinity tag (e.g., His-tag) for purification

  • Purify using affinity chromatography followed by size exclusion chromatography

  • Verify purity by SDS-PAGE and Western blotting

• Direct kinase activity assays:

  • ATP consumption assay: Measure decrease in ATP levels using luminescence-based methods

  • ADP production assay: Couple ADP production to NADH oxidation through pyruvate kinase and lactate dehydrogenase

  • Radiometric assay: Use 32P-ATP to directly measure phosphate incorporation into substrate

• Substrate preparation:

  • Use commercially available D-ribulose as the primary substrate

  • Include alternative sugar substrates as controls to demonstrate specificity

  • Prepare substrate solutions fresh before each assay

• Reaction conditions optimization:

  • Buffer composition (typically HEPES or Tris at pH 7.0-8.0)

  • Divalent cation requirements (Mg2+ or Mn2+)

  • Temperature (25-37°C)

  • Reaction time course to ensure linear reaction rates

• Enzyme kinetics determination:

  • Measure initial velocities at varying substrate concentrations

  • Determine Km and Vmax values for D-ribulose and any alternative substrates

  • Calculate catalytic efficiency (kcat/Km) to quantify substrate preference

• Product verification:

  • LC-MS confirmation of phosphorylated products

  • Phosphate release assays using malachite green or similar methods

How can researchers address non-specific binding with YDR109C antibodies?

Non-specific binding is a common challenge with antibodies against relatively low-abundance proteins like YDR109C. To address this issue:

• Optimization of blocking conditions:

  • Test different blocking agents (5% milk, 3-5% BSA, commercial blocking buffers)

  • Increase blocking time (2-3 hours at room temperature or overnight at 4°C)

  • Add 0.1-0.3% Tween-20 to blocking buffer to reduce hydrophobic interactions

• Antibody dilution optimization:

  • Test a range of primary antibody dilutions (1:500 to 1:5000)

  • Perform dilution in freshly prepared blocking buffer

  • Consider longer incubation at lower concentrations (overnight at 4°C)

• Washing protocol enhancement:

  • Increase number of washes (5-6 times instead of standard 3)

  • Extend washing time (15 minutes per wash)

  • Add higher concentration of Tween-20 (0.1-0.2%) or low concentration of SDS (0.01-0.05%) to wash buffer

• Pre-adsorption techniques:

  • Pre-incubate antibody with extracts from YDR109C knockout strains to adsorb antibodies that bind to non-specific targets

  • Use commercially available pre-adsorption matrices

• Alternative detection systems:

  • Try fluorescent secondary antibodies instead of HRP-conjugated ones

  • Use signal amplification systems designed for low-abundance proteins

• Sample preparation refinement:

  • Include additional purification steps for protein extracts

  • Consider subcellular fractionation to enrich for compartments where YDR109C is localized

What are the critical factors for reproducible metabolomics analysis of YDR109C function?

Ensuring reproducible metabolomics analysis when studying YDR109C function requires attention to several critical factors:

• Sample preparation standardization:

  • Harvest cells at consistent growth phases (mid-log phase recommended)

  • Rapid quenching of metabolism (cold methanol or liquid nitrogen)

  • Consistent extraction protocols with internal standards

  • Process all comparative samples in parallel

• Analytical method considerations:

  • Use multiple complementary methods (ZIC-HILIC and reverse phase chromatography)

  • Implement both positive and negative ionization modes to maximize coverage

  • Include quality control samples (pooled samples run periodically throughout the sequence)

  • Use both untargeted and targeted approaches for comprehensive coverage

• Data processing and normalization:

  • Consistent peak picking and integration methods

  • Appropriate normalization (mTIC normalization has been effective)

  • Correction for batch effects and systematic drift

• Statistical rigor:

  • Sufficient biological replicates (minimum n=3, preferably n=5 or greater)

  • Appropriate statistical tests (Welch's t-test for unequal variances has been used successfully)

  • Multiple testing correction (FDR or Bonferroni)

  • Multivariate analysis (PCA and PLS-DA) for pattern recognition

• Metadata documentation:

  • Detailed recording of all experimental conditions

  • Growth media composition (especially for auxotrophic strains)

  • Cell density at harvest

  • Extract concentration and storage conditions

• Biological variables control:

  • Test in multiple genetic backgrounds to identify core versus strain-specific changes

  • Control for auxotrophic markers that may influence metabolism

  • Consider the impact of growth conditions and media composition

How can researchers distinguish between technical and biological variability in YDR109C studies?

Distinguishing between technical and biological variability is crucial for robust research on YDR109C:

What are the most promising approaches for studying YDR109C interactions with other proteins?

Several approaches show promise for investigating YDR109C protein interactions:

• Affinity purification coupled with mass spectrometry (AP-MS):

  • Express tagged versions of YDR109C (TAP-tag or FLAG-tag)

  • Purify under native conditions to maintain protein complexes

  • Identify co-purifying proteins by mass spectrometry

  • Include appropriate controls (untagged strains, tag-only controls)

• Proximity-dependent labeling approaches:

  • Express YDR109C fused to BioID or APEX2

  • These enzymes biotinylate proteins in close proximity to YDR109C in vivo

  • Purify biotinylated proteins and identify by mass spectrometry

  • Provides information about transient interactions and spatial proximity

• Yeast two-hybrid screening:

  • Use YDR109C as bait to screen for interacting proteins

  • Validate positive hits with orthogonal methods

  • Consider split-ubiquitin systems for membrane-associated interactions

• Co-immunoprecipitation with targeted candidates:

  • Based on metabolic pathway analysis, test specific candidates

  • Focus on proteins involved in ribulose metabolism or related sugar-phosphate pathways

  • Use reciprocal tagging to confirm interactions

• Genetic interaction screening:

  • Synthetic genetic array (SGA) analysis with YDR109C deletion

  • Identify genes whose deletion enhances or suppresses YDR109C phenotypes

  • These often indicate functional relationships or compensatory pathways

• Co-expression analysis:

  • Identify genes with expression patterns that correlate with YDR109C

  • Use existing transcriptomic datasets or generate condition-specific data

  • Test candidate interactors based on co-expression patterns

How might researchers apply structural biology techniques to YDR109C studies?

Applying structural biology techniques to YDR109C research would provide valuable insights into its function:

What experimental approaches could elucidate the evolutionary conservation of YDR109C function?

Understanding the evolutionary conservation of YDR109C function requires several complementary approaches:

• Comparative genomics analysis:

  • Identify homologs across diverse species using sequence similarity searches

  • Analyze conservation patterns of key domains (FGGY_N and FGGY_C)

  • Map conservation onto structural models to identify critical functional regions

• Functional complementation studies:

  • Express homologs from other species in S. cerevisiae YDR109C knockout strains

  • Test rescue of metabolic phenotypes, particularly ribulose accumulation

  • Compare kinetic parameters of homologs using in vitro enzymatic assays

• Metabolomic profiling across species:

  • Analyze metabolic consequences of YDR109C homolog disruption in diverse organisms

  • Look for conserved metabolite changes, particularly in ribulose levels

  • Use standardized methods to allow direct comparison across species

• Phylogenetic analysis coupled with functional data:

  • Construct detailed phylogenetic trees of the FGGY family

  • Map functional data (substrate specificity, expression patterns) onto trees

  • Identify potential instances of functional divergence or convergence

• Comparative expression analysis:

  • Analyze expression patterns of YDR109C homologs across different species

  • Identify conserved regulatory elements in promoter regions

  • Test if expression regulation is maintained across evolutionary distance

• Cross-species protein-protein interaction studies:

  • Compare interactomes of YDR109C homologs across species

  • Identify conserved interaction partners that may indicate functional modules

  • Test if human FGGY interactions are conserved in the yeast system

What are the broader implications of YDR109C research for understanding eukaryotic metabolism?

Research on YDR109C extends beyond yeast biology to provide insights into fundamental aspects of eukaryotic metabolism. As a previously uncharacterized gene now identified as a ribulokinase, YDR109C research contributes to our understanding of sugar metabolism, particularly pentose processing pathways that are conserved across evolution. The dramatic metabolic changes observed in YDR109C knockout strains, with over 30-fold accumulation of ribulose, highlight the importance of this enzyme in maintaining metabolic homeostasis .

The human homolog FGGY shares substrate specificity for D-ribulose, suggesting conservation of this metabolic function from yeast to humans . This conservation indicates that findings from the yeast model may have direct relevance to human metabolism and potentially to metabolic disorders. Furthermore, understanding YDR109C function contributes to completing our knowledge of the yeast metabolic network, which serves as a template for understanding more complex eukaryotic systems.

The methodological approaches developed for studying YDR109C, particularly the integration of genetic manipulation with metabolomics analysis, provide a framework for investigating other uncharacterized genes across species. These systems biology approaches help bridge the gap between genotype and phenotype by revealing the specific metabolic consequences of gene disruption.

What standardized reporting should researchers follow when publishing YDR109C antibody studies?

When publishing research using YDR109C antibodies, researchers should adhere to the following standardized reporting guidelines:

• Antibody specifications:

  • Commercial source or generation method if custom-made

  • Catalog number and lot number for commercial antibodies

  • Immunogen sequence and host species

  • Monoclonal or polyclonal nature

  • Isotype for monoclonal antibodies

• Validation documentation:

  • Evidence of specificity (western blots showing presence in WT and absence in knockout)

  • Cross-reactivity testing with related proteins

  • Concentration/dilution used in each application

  • Secondary antibody details

• Experimental conditions:

  • Detailed immunoblotting protocols including blocking agents and times

  • Sample preparation methods

  • Protein quantification method

  • Loading controls used

  • Image acquisition settings

• Controls and reproducibility:

  • Inclusion of appropriate positive and negative controls

  • Number of experimental replicates

  • Quantification methods for band intensity

  • Statistical analysis approaches

• Data availability:

  • Raw images of complete blots

  • Quantification data and analysis scripts

  • Sharing antibody resources with research community when possible

• Resource identification:

  • Use of unique identifiers like Research Resource Identifiers (RRIDs)

  • Deposition of relevant information in antibody databases

  • Clear declaration of any commercial interests or conflicts